See all
 |
Articles: Demyelinating Disorders |
Prior Articles
Steady-state pharmacokinetics and tolerability of orally administered fampridine sustained-Release 10-mg tablets in patients with multiple sclerosis: A 2-week, open-label, follow-up study
Clinical Therapeutics, 11/19/09
Pharmacokinetics and tolerability of single escalating doses of fampridine sustained-release tablets in patients with multiple sclerosis: A phase I–II, open-label trial
Clinical Therapeutics, 11/19/09 Fatigue and Quality of Life in Pediatric Multiple Sclerosis
Multiple Sclerosis, 11/18/09 Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Trondelag County, Norway
Multiple Sclerosis, 11/18/09 New oral drugs for multiple sclerosis
Neurological Sciences, 11/18/09 Cyclophosphamide as second-line therapy in multiple sclerosis: benefits and risks
Neurological Sciences, 11/18/09 Mitoxantrone: benefits and risks in multiple sclerosis patients
Neurological Sciences, 11/18/09 Relationship between Barkhof criteria and the clinical features of multiple sclerosis in northern Japan
Multiple Sclerosis, 11/18/09 Association of anti-Helicobacter pylori neutrophil-activating protein antibody response with anti-aquaporin-4 autoimmunity in Japanese patients with multiple sclerosis and neuromyelitis optica
Multiple Sclerosis, 11/18/09 Influence of interferon-beta therapy switching on neutralising antibody titres: results from the Austrian Switch Study (ASS)
Multiple Sclerosis, 11/18/09 Association of susceptibility to multiple sclerosis in Southern Han Chinese with HLA-DRB1, -DPB1 alleles and DRB1-DPB1 haplotypes: distinct from other populations
Multiple Sclerosis, 11/18/09 Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients
Multiple Sclerosis, 11/18/09 Treatment of multiple sclerosis: role of natalizumab
Neurological Sciences, 11/18/09 Macular Volume Determined by Optical Coherence Tomography as a Measure of Neuronal Loss in Multiple Sclerosis
Archives of Neurology, 11/17/09 Optical Coherence Tomography in Clinically Isolated Syndrome: No Evidence of Subclinical Retinal Axonal Loss
Archives of Neurology, 11/17/09 Utility of the distal compound muscle action potential duration for diagnosis of demyelinating neuropathies
Journal of the Peripheral Nervous System, 11/16/09 The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseases
Sleep Medicine Reviews, 11/16/09 The existence of phonatory instability in multiple sclerosis: an acoustic and electroglottographic study
Neurological Sciences, 11/16/09 Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score
The Lancet Neurology, 11/13/09 Cervical spondylotic amyotrophy presenting as dropped head syndrome
Clinical Neurology and Neurosurgery, 11/13/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Current Opinion in Neurology, Stroke, Seizure, Cephalgia, Brain Injury
more...
|
250 Available Pages
|
|